Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Type of study
Language
Year range
1.
Afr. J. Clin. Exp. Microbiol ; 13(2): 110-117, 2012. tab
Article in English | AIM | ID: biblio-1256061

ABSTRACT

Data on campylobacteriosis are almost nonexistent in Burkina Faso. In this study conducted from 2006 to 2008 in Ouagadougou; stool specimens and sociodemographic data were collected from 1 246 patients attending the university teaching hospital for enteritis. Stool samples were analyzed for the presence of Campylobacter by the direct culture method on selective mCCDA agar followed by antibiotic susceptibility testing on the isolated strains. The isolation rate of Campylobacter was 2.3;comprising of the following species C. jejuni (51.8); C. coli (13.8); and C. upsaliensis (3.5). However; 30.9of the isolates were unidentified. No resistant strain was found to gentamicin. The resistance to amoxicillin+clavulanic acid (3.4) was lower than those (10.3-34.5) to the other antibiotics: erythromycin (10.3); tetracycline (10.3); ciprofloxacin (13.8); amoxicillin (24.1) and ceftriaxone (34.5); nalidixic acid (34.5). Significant associations were found between Campylobacter enteritis and contact with animals (P=0.03); and HIV infection (P0.0001); in contrast to other sociodemographic and seasonal factors. From the data obtained Amoxicillin+clavulanic acid appear to be the first choice for treatment. The implementation of a national program may be helpful in controlling the spread of the disease and the increase of resistance to antibiotics


Subject(s)
Anti-Infective Agents , Burkina Faso , Campylobacter , Drug Resistance , HIV Infections/epidemiology
2.
Ann. afr. med ; 9(1): 5-10, 2010.
Article in English | AIM | ID: biblio-1259023

ABSTRACT

Background: Tuberculosis drug-resistance becomes common in sub-Saharan Africa; however; very few data are available in Burkina Faso. The aim of this study is to assess the acquired resistance of Mycobacterium tuberculosis complex strains identified in TB patients to four first-line drugs in Ouagadougou. Methods: One hundred and ten (110) pulmonary tuberculosis patients with acid-fast bacilli-positive sputum and in situation of failure; relapse; or treatment abandonment were included in the study. Ninety six strains; including 92 (95.8) M. tuberculosis and 4 (4.2) M. africanum; were isolated from the sputum samples of these patients. Their drug susceptibility testing was performed using the proportion method. The first-line drugs tested were isoniazid (INH); streptomycin (STR); ethambutol (EMB); and rifampicin (RIF). Results: The overall drug-resistance rate of M. tuberculosis was 67.4(n=60); including 3.4to one drug; 18to two; 10.1to three; and 35.9to four drugs. The resistance to INH; RIF; EMB; and STR were 67.4; 51.7; 50.6; and 44.9; respectively. Two strains of M. africanum were resistant to all drugs. Forty-six (51.7) strains were multidrug-resistant (resistant to at least INH and RIF). Conclusions: In previously treated patients; the level of resistance of M. tuberculosis complex to commonly used anti-tuberculosis drugs is very high in Ouagadougou. Our results showed that multidrug-resistant tuberculosis could be a public health problem in Burkina Faso


Subject(s)
Drug Resistance , Mycobacterium tuberculosis , Patients
SELECTION OF CITATIONS
SEARCH DETAIL